Sentences with phrase «traffic regulations in»

He / she must have expansive knowledge of road signs and traffic regulations in the city he / she operates

Traffic regulations in a large number of countries require trucks to always drive with an engaged gear, which in turn provides a certain amount of engine braking (viscous losses to the engine oil and air pumped through the engine and friction losses to the cylinder walls and bearings) when no accelerator pedal is applied.

There's an element - a bit like choosing to obey traffic regulations in games like Grand Theft Auto - where you realise your own commute is probably more entertaining.

Not exact matches

«Belarus is on a special «International Traffic in Arms Regulations» list published by the U.S. State Department, of countries with bans or special restrictions,» Roston writes.

Under the new regulations, ISPs would be able to charge the data hogs more to cover the cost of investing in their networks to accelerate all that extra video traffic.

For «law - abiding citizens» this does not generally require the penalties of the law to be invoked, though one need only to ask himself how far his driving is affected by known traffic regulations, or his income - tax filing by fear of penalties, to realize the degree to which the law is in the background as a restraint to his self - centeredness.

We create traffic signals, speed limits, food regulations, health inspections, and other restraints on our freedom in order to maintain values of health and safety.

Even if measures supported by the best available evidence (such as traffic light labelling on the front - of - food packaging and removing advertising junk food to children between 6 am and 9 pm as recommended in the Government's response to the National Preventative Health Taskforce) are implemented, regulation is no panacea.

Added February 2018: On 1 May 2016, a traffic light labelling system for beverages was implemented in Sri Lanka after the government introduced a regulation under Section 32 of the Food Act, No. 26 of 1980.

Before and since the whalers it has been the landfall for westbound Atlantic shipping, and today its name is bandied about the skies as a key point in the regulation of transoceanic aerial traffic.

From time to time, we may use your Personal Information and Traffic Data: (a) if we need to respond to valid legal process, including, but not limited to, a search warrant, subpoena, or court order, and any other instance when we believe we are required to do so by law; or (b) if we deem it necessary to disclose Personal Information or Traffic Data, in our sole discretion, to comply with any applicable law, regulation, legal process or governmental request, or to protect our rights or interests.

Harrington added: «British Cycling does not, as a matter of principle, believe that the correct way to address the safety of cyclists is by banning the activity altogether, and that the successful implementation of this Traffic Regulation Order could have far - reaching implications for cycling here in the UK which are contrary to Highways England's own Cycling Strategy.

Added regulations on the helicopter industry established last year have proven unsuccessful, according to the stakeholders, as Brooklyn residents continue to be disrupted by chopper noise and traffic — in part due to the elimination -LSB-...]

Omeje appealed to the tanker drivers to imbibe the culture of obeying the traffic rules and regulations and consider other road users in the course of their journey.

In a statement, AT&T said that while it does not «throttle or degrade» web traffic it opposes attempts to create state - based internet regulations that would «confuse consumers, harm competition and impede innovation and investment.»

He told The Real Deal he would like to make the city more business - friendly, complaining that his company's delivery trucks incur thousands of dollars in parking and traffic tickets near his warehouse in Hunts Point, and that regulations should be eased on large employers.

The US's International Traffic in Arms Regulations controls the export of strong encryption techniques, defining them as munitions.

In an effort to reduce its notoriously bad traffic problems, Jakarta installed its HOV regulations in 1992, using a «three - in - one» policy that required three passengers in each vehicle on some major roads, between 7 and 10 a.m. and between 4:30 and 7 p.m.. However, it suddenly scrapped the policy in 2016 — first for a week, then for a month, and then permanentlIn an effort to reduce its notoriously bad traffic problems, Jakarta installed its HOV regulations in 1992, using a «three - in - one» policy that required three passengers in each vehicle on some major roads, between 7 and 10 a.m. and between 4:30 and 7 p.m.. However, it suddenly scrapped the policy in 2016 — first for a week, then for a month, and then permanentlin 1992, using a «three - in - one» policy that required three passengers in each vehicle on some major roads, between 7 and 10 a.m. and between 4:30 and 7 p.m.. However, it suddenly scrapped the policy in 2016 — first for a week, then for a month, and then permanentlin - one» policy that required three passengers in each vehicle on some major roads, between 7 and 10 a.m. and between 4:30 and 7 p.m.. However, it suddenly scrapped the policy in 2016 — first for a week, then for a month, and then permanentlin each vehicle on some major roads, between 7 and 10 a.m. and between 4:30 and 7 p.m.. However, it suddenly scrapped the policy in 2016 — first for a week, then for a month, and then permanentlin 2016 — first for a week, then for a month, and then permanently.

Now, the U.S. government closely regulates export of space - related technologies under rules known as the International Traffic in Arms Regulations (ITAR), which are overseen by the U.S. Department of State.

These foreign nationals have allegedly obtained NASA secrets and cutting edge technology while not possessing the proper clearance in violation of International Traffic in Arms Regulations (ITAR).

At issue are the International Traffic in Arms Regulations (ITAR), which are supposed to prevent technological secrets ending up in the hands of 21 proscribed nations, including China, Iran and North Korea.

His lab applies automated high - content screening microscopy to understand the regulation of membrane traffic pathways in mammalian cells.

Transmembrane protein OSTA - 1 shapes sensory cilia morphology via regulation of intracellular membrane trafficking in C. elegans.

He ranted against the International Traffic in Arms Regulations (ITAR), saying that Bigelow had to spend about $ 1 million to comply with ITAR when it launched two test inflatable modules on Russian launch vehicles.

A number of downregulated pathways in the regular meditator group versus the other groups defined the meditation effect, including regulation of protein synthesis and trafficking, viral expression and viral infectious cycle.

Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) trRegulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) trRegulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) trRegulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) trregulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) trregulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) trregulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) trregulation of expression and function of the ATP - binding cassette (ABC) transporters

We demonstrate a novel outcome of S1P - mediated regulation of lymphocyte trafficking, whereby deletion of Spns2, either globally or in a lymphatic endothelial - specific manner, creates a circulating lymphopenia and a higher percentage of effector T cells and natural killer (NK) cells present in the lung.

for all students, instruction in highway safety and traffic regulation, as required by section 806 of the Education Law;

The catch is that Traffic Jam Pilot — which qualifies as SAE International Level 3 autonomy in that you can drive hands - free — won't be available in the U.S. at launch due to safety regulations here.

The National Highway Traffic Safety Administration has shown no interest in promulgating regulations, which leaves the ball in the manufacturers» court.

Positions in this occupation require an extensive knowledge of the laws, rules, regulations and procedures governing the movement of air traffic.

Prior to this, he worked in the regulations division of the National Highway Traffic Safety Administration (NHTSA) Chief Counsel's Office, and he served as a line officer in the United States Navy.

It was also interesting to note that some of the new regulations put in place to keep traffic moving seemed to work as cars were moving along better than we recall seeing in Birmingham in past years.

When the Model S was tested by the National Highway Traffic Safety Administration for the United States safety regulations, and its results were published in August of 2013, it achieved the highest score ever recorded.

Back in the 1970s and 80s, as a departmental director at the National Highway Traffic Safety Administration (NHTSA) in the USA, the scientist played a major role in channelling the latest findings from accident research into statutory regulations governing the inclusion of active and passive safety technology in vehicles.

Providing all this information and complying with different regulations that govern it is no walk in the park — and we haven't even mentioned different public information posters that certain countries prescribe must be put up, such as for example the USA slavery and human trafficking public notice that must be displayed in all airports, emergency rooms, truck stops and roadside rest areas.

In order to prevent snowballing debt for residents, states across the country have implemented their own regulations to traffic payday loans.

«Unfortunately due to a court ruling, British travellers can not claim any compensation if delays or cancellations are caused by a French Air Traffic Control strikes, because strike action is considered «extraordinary», a key qualifying factor in the EU regulation that governs what can and can not be claimed for.»

By William Ysaguirre Freelance Reporter The enforcement of traffic laws and Department of Transport regulations caused some embarrassment for the operators of shuttle bus services to Ladyville and Burrell Boom on Tuesday, April 4, when some operators were found to be not in compliance with the terms of their road -LSB-...]

The Code calls upon tourists to behave in a responsible and respectful manner towards the visited destination, urging them not to commit any criminal acts and to refrain from all trafficking in illicit drugs, arms, antiques, protected species, products and substances that are dangerous or prohibited by national regulations.

La Mariposa Hotel assumes no responsibility for injury, loss or damage to person or property in connection with any service resulting directly from acts of God, detention annoyance, strikes, riots, civil disturbances, quarantines, weather conditions, traffic delays, flights delays, government restrictions or regulations.

However, in recent years, this character has been seriously threatened by numerous large - scale buildings that have been designed and constructed without adhering to zoning regulations, and with disregard for infrastructure capacity, traffic, parking, or the resulting loss of affordable housing.

Newman notes that new regulations in Shanghai and Beijing make it very difficult to actually buy a car, and traffic in urban areas in both nations make getting around by car slow at best.

And of course, there is little regulation of this; According to AP, «under pressure from the industry, the National Highway Traffic Safety Administration in 2012 issued voluntary safety guidelines to automakers for dashboard technology instead of enforceable safety standards.»

It also clears the way for motor accident victims to seek redress directly from the Motor Insurers» Bureau (MIB) by relying exclusively on European Union (EU) law, independently of the complex and sometimes conflicting provisions of Pt VI of the Road Traffic Act 1988; the European Communities Rights Against Insurers Regulations 2002; the Motor Vehicles (Compulsory Insurance)(Information Centre and Compensation Body) Regulations 2003 and / or the MIB's private law agreements with the Secretary of State for Transport set out in four concurrent schemes.

Several days later, Wilson received a letter from the State Department ordering the removal of the designs from the site pending review of whether publishing them constituted distribution of «technical data» in violation of the International Traffic in Arms Regulations.

The Federal Motor Carrier Safety Regulations, contained in the Code of Federal Regulations, applies to all vehicles engaged in interstate traffic, has specific provisions governing hours of service for drivers (see 49 C.F.R. § 395 for more information).

The Appellants» submission that any departure, other than one which was trivial, from the definition of a «controlled parking zone» in regulation 4 of the Traffic Signs Regulations and General Directions 2002 invalidated the entire controlled parking zone was rejected.

The true legal representative, like a car accident lawyer in Mc Allen, would be knowledgeable about the most common conditions leading to the shocking number of car accidents in Texas occurring due to thoughtless driving, lack of adherence to traffic regulations and awareness about driving conditions.

While these automobile verse pedestrian accidents are more common in urban areas and cities, they can happen anywhere if drivers and pedestrians fail to pay attention and adhere to traffic regulations.